Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of serum malondialdehyde in patients treated with chlorpromazine.

A Bindoli1, M P Rigobello, L Cavallini

  • 1Centro Studio Fisiologia Mitocondriale CNR, Vicenza, Italy.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|November 16, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Milk-derived bioactive peptides protect against oxidative stress in a Caco-2 cell model.

Food & function·2018
Same author

Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162].

Redox biology·2017
Same author

Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface.

Cell death & disease·2013
Same author

Effect of dopamine and glutamate on the ATP-stimulated calcium uptake by rat synaptosomes.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Real-time digital holographic microscopy of multiple and arbitrarily oriented planes.

Optics letters·2011
Same author

[Nephrogenic systemic fibrosis].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2008

Chlorpromazine treatment significantly reduced malondialdehyde levels in schizophrenic patients, indicating its effectiveness in lowering serum lipid peroxides. This suggests chlorpromazine

Area of Science:

  • Biochemistry
  • Neuroscience
  • Pharmacology

Background:

  • Schizophrenia is a complex psychiatric disorder associated with oxidative stress.
  • Elevated levels of lipid peroxidation products, such as malondialdehyde, have been observed in patients with schizophrenia.

Purpose of the Study:

  • To investigate the effect of chlorpromazine treatment on serum malondialdehyde levels in schizophrenic patients.
  • To explore the potential antioxidant properties of chlorpromazine in the context of schizophrenia.

Main Methods:

  • Serum malondialdehyde levels were measured in schizophrenic patients before and after treatment with chlorpromazine.
  • Statistical analysis was performed to compare pre- and post-treatment values.

Main Results:

Related Experiment Videos

  • Serum malondialdehyde levels were significantly lower in schizophrenic patients after chlorpromazine treatment compared to pre-treatment levels.
  • The reduction in malondialdehyde suggests a decrease in lipid peroxidation.

Conclusions:

  • Chlorpromazine exhibits antioxidant properties, evidenced by its ability to reduce serum lipid peroxides in schizophrenic patients.
  • These antioxidant effects may contribute to the neuroleptic action of chlorpromazine in managing schizophrenia.